SARS-COV-2 has roused the scientific community with a call to action to combat the growing
pandemic. At the time of this writing, there are as yet no novel antiviral agents or approved …

Antimicrobial peptides (AMPs) are ubiquitously present small peptides, which play a critical
function in the innate immune system. The defensin class of AMPs represented an …

The recent outbreak of the coronavirus (SARS-CoV2) is an unprecedented threat to human
health and society across the globe. In this context, development of suitable interventions is …

Previous studies reported that Angiotensin converting enzyme 2 (ACE2) is the main cell
receptor of SARS-CoV and SARS-CoV-2. It plays a key role in the access of the virus into the …

SARS-CoV-2 has caused the largest pandemic of the twenty-first century (COVID-19),
threatening the life and economy of all countries in the world. The identification of novel …

It has been 3 years since the beginning of the SARS-CoV-2 outbreak, however it is as yet
little known how to care for the acute COVID-19 and long COVID patients. COVID-19 clinical …

Human-derived antimicrobial peptides (AMPs), such as defensins and cathelicidin LL-37,
are members of the innate immune system and play a crucial role in early pulmonary …

A serious pandemic has been caused by the severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2). The interaction between spike surface viral protein (Sgp) and the …

Antimicrobial peptides (AMPs), α-and β-defensins, possess antiviral properties. These AMPs
achieve viral inhibition through different mechanisms of action. For example, they can:(i) …

As the current worldwide outbreaks of the SARS-CoV-2, it is urgently needed to develop
effective therapeutic agents for inhibiting the pathogens or treating the related diseases …